MARKET

GLPG

GLPG

Galapagos
NASDAQ

Real-time Quotes | Nasdaq Last Sale

274.03
+13.99
+5.38%
After Hours: 274.03 0 0.00% 16:17 02/21 EST
OPEN
267.95
PREV CLOSE
260.04
HIGH
274.03
LOW
266.55
VOLUME
345.98K
TURNOVER
--
52 WEEK HIGH
274.03
52 WEEK LOW
94.75
MARKET CAP
16.98B
P/E (TTM)
56.90
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GLPG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GLPG stock price target is 208.61 with a high estimate of 299.28 and a low estimate of 174.58.

EPS

GLPG News

More
  • Galapagos NV (GLPG) CEO Onno van de Stolpe on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 1d ago
  • Galapagos reports Q4 results
  • seekingalpha · 1d ago
  • Galapagos NV 2019 Q4 - Results - Earnings Call Presentation
  • Seeking Alpha - Article · 1d ago
  • Galapagos +3% premarket on FY results
  • Seeking Alpha - Article · 1d ago

Industry

Biotechnology & Medical Research
+0.37%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About GLPG

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.
More

Webull offers kinds of Galapagos NV stock information, including NASDAQ:GLPG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLPG stock news, and many more online research tools to help you make informed decisions.